Yonkenafil (hydrochloride)
Yonkenafil (Tunodafil) hydrochloride, a novel phosphodiesterase 5 (PDE5) inhibitor, is effective in reducing cerebral infarction, neurological deficits, edema, and neuronal damage in the infarcted area. Yonkenafil (Tunodafil) hydrochloride may improve cognitive function by modulating neurogenesis and has a potential therapeutic effect on Alzheimer's disease[1].
Product Specifications
CAS Number
804519-64-0
Product Name Alternative
Tunodafil (hydrochloride)
UNSPSC
12352005
Target
Phosphodiesterase (PDE)
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease; Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/yonkenafil-hydrochloride.html
Concentration
10mM
Purity
99.43
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C1C2=C(N=C(N1)C3=CC(S(=O)(N4CCN(CC4)CC)=O)=CC=C3OCC)N(C=C2C)CCC.[H]Cl
Molecular Formula
C24H34ClN5O4S
Molecular Weight
524.08
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture and light)
Scientific Category
Reference compound1
Clinical Information
Phase 1
Isoform
PDE5
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
GATA-3 (Breast and Urothelial Marker) (GATA3/2442), CF740 conjugate, 0.1mg/mL
Sterol carrier protein 2 (SCP2) (NM_001193600) Human Over-expression Lysate
ACTH (Adrenocorticotrophic Hormone) (2F6), CF647 conjugate, 0.1mg/mL
